Why Option Care Health Stock Zoomed 8% Higher on Tuesday

Source The Motley Fool

Key Points

  • It released its preliminary quarterly and full-year 2025 figures.

  • These indicated a healthy year-over-year rise in revenue and a potential bottom-line bump.

  • 10 stocks we like better than Option Care Health ›

Many investors were opting to grab shares of Option Care Health (NASDAQ: OPCH) during Tuesday's trading session. This followed the niche healthcare company's announcement of preliminary financial results. Encouraged by what they heard, those market players pushed Option Care Health's price up by over 8% that day.

Preliminary optimism

After market close Monday, Option Care Health unveiled those preliminary and unaudited figures. For its fourth quarter of 2025, the company anticipates booking $1.46 billion to $1.47 billion in net sales, compared to $1.35 billion in the same period the previous year.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »

Two people participating in a telehealth session.

Image source: Getty Images.

As for profitability, Option Care Health estimates it will earn net income not in accordance with generally accepted accounting principles (GAAP) of $73.8 million to $79 million for the quarter. That shakes out to $0.46 to $0.49 per share. The year-ago quarter's non-GAAP (adjusted) net profit was $75.5 million.

The company also announced it is expanding its share buyback program. Its board of directors has authorized management to repurchase up to $1 billion of its equity, exactly double the $500 that was authorized last year. At the end of 2025, that original program had $193 million remaining in purchase capacity.

Positive prognosis

In contrast to an "official" earnings release, a preliminary one doesn't necessarily offer commentary on the covered quarter. Option Care Health didn't discuss either its fourth quarter or full-year performance at all.

Regardless, the company's doubling of its stock buyback initiative shows it's heading into the still-new year with plenty of confidence in its business. If I were a shareholder, I'd also be encouraged by that more than 8% year-over-year increase in revenue.

Should you buy stock in Option Care Health right now?

Before you buy stock in Option Care Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Option Care Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $482,209!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,133,548!*

Now, it’s worth noting Stock Advisor’s total average return is 968% — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of January 13, 2026.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Ethereum (ETH) Price Closes Above $3,900 — Is a New All-Time High Possible Before 2024 Ends?Once again, the price of Ethereum (ETH) has risen above $3,900. This bounce has hinted at a further price increase for the altcoin before the end of the year.
Author  Beincrypto
Dec 17, 2024
Once again, the price of Ethereum (ETH) has risen above $3,900. This bounce has hinted at a further price increase for the altcoin before the end of the year.
placeholder
ECB Policy Outlook for 2026: What It Could Mean for the Euro’s Next MoveWith the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
Author  Mitrade
Dec 26, 2025
With the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
placeholder
WTI surges to $73 as Strait of Hormuz closure prompts supply shocksWest Texas Intermediate (WTI), futures on NYMEX, trades 2.3% higher to $73.00 during the early European trading session on Tuesday.
Author  FXStreet
20 hours ago
West Texas Intermediate (WTI), futures on NYMEX, trades 2.3% higher to $73.00 during the early European trading session on Tuesday.
placeholder
Gold rises for fifth day on Middle East tensions, modest USD pullbackGold (XAU/USD) catches fresh bids following the previous day's two-way price swings and trades with modest gains above the $5,350 level, during the Asian session on Tuesday.
Author  FXStreet
20 hours ago
Gold (XAU/USD) catches fresh bids following the previous day's two-way price swings and trades with modest gains above the $5,350 level, during the Asian session on Tuesday.
placeholder
Pound Sterling continues to underperform amid US-Israel war with IranThe Pound Sterling (GBP) trades lower against its major currency peers, slides 0.3% to near 1.3360 against the US Dollar (USD) during the European trading session on Tuesday.
Author  FXStreet
20 hours ago
The Pound Sterling (GBP) trades lower against its major currency peers, slides 0.3% to near 1.3360 against the US Dollar (USD) during the European trading session on Tuesday.
goTop
quote